A Study of Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFR

NCT02687386 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Study medication no longer in production

Conditions

Solid Tumours
CNS Tumours

Interventions

DRUG: Mitoxantrone packaged EDV (EnGeneIC Delivery Vehicle)

Sponsor

Dr David Ziegler

Collaborators

[object Object]